Regulation of beta cell replication

Molecular and Cellular Endocrinology

Volumn 297, Issue 1-2, 2009, Pages 18-27

  Lee, Ying C ^a   Nielsen, Jens Høiriis ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Beta cells; Diabetes; Growth factors; Islets; Replication

Indexed keywords

ARF PROTEIN; CYCLIN D1; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLIN DEPENDENT KINASE INHIBITOR 2C; CYCLIN DEPENDENT KINASE INHIBITOR 2D; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; GROWTH FACTOR; GROWTH HORMONE; INSULIN; METHIONINE; PROLACTIN; WNT PROTEIN;

CELL AGING; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CELL HYPERPLASIA; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; FEEDBACK SYSTEM; GENETIC TRANSCRIPTION; GLUCOSE TOLERANCE; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL AGING; CELL DIVISION; CYCLIN-DEPENDENT KINASES; CYCLINS; HUMANS; INSULIN-SECRETING CELLS; PROTO-ONCOGENE PROTEINS;

EID: 57649210751     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.08.033     Document Type: Review

References (120)

1. Alonso L.C., Yokoe T., Zhang P., Scott D.K., Kim S.K., O'Donnell C.P., and Garcia-Ocaña A. Glucose infusion in mice a new model to induce β-cell replication. Diabetes 56 (2007) 1792-1801
2. Bernal-Mizrachi E., Wen W., Stahlhut S., Welling C.M., and Permutt M.A. Islet beta cell expression of constituitively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J. Clin. Invest. 108 (2001) 1631-1638
3. Bonner-Weir S., Baxter L.A., Schuppin G.T., and Smith F.E. A second pathway for regeneration of adult exocrine and endocrine pancreas: a possible recapitulation of embryonic development. Diabetes 42 (1993) 1715-1720
4. Bonner-Weir S., Deery D., Leahy J.L., and Wei G.C. Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion. Diabetes 38 (1989) 49-53
5. Bonner-Weir S., and Weir G.C. New sources of pancreatic beta-cells. Nat. Biotechnol. 23 (2005) 857-861
6. Boucher M.-J., Selander L., Carlsson L., and Edlund H. Phosphorylation marks IPF1/PDX1 protein for degradation by glycogen synthase kinase 3-dependent mechanisms. J. Biol. Chem. 281 (2006) 6395-6403
7. Brennand K., Huangfu D., and Melton D. All beta cells contribute equally to islet growth and maintenance. PLoS Biol. 5 (2007) e163
8. Brun T., He K.H., Lupi R., Boehm B., Wojtusciszyn A., Sauter N., Donath M., Marchetti P., Maedler K., and Gauthier B.R. The diabetes-linked transcription factor Pax4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1. Hum. Mol. Genet. 17 (2008) 478-489
9. Brüning J.C., Winnay J., Bonner-Weir S., Taylor S.I., Accili D., and Kahn C.R. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88 (1997) 561-572
10. Buteau J., Foisy S., Joly E., and Prentki M. Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 52 (2003) 124-132
11. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., and Butler P.C. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52 (2003) 102-110
12. Butler P.C., Meier J.J., Butler A.E., and Bhushan A. The replication of β cells in normal physiology, in disease and for therapy. Nat. Clin. Pract. Endocrinol. Metab. 3 (2007) 758-768
13. Cheng M., Olivier P., Diehl J.A., Fero M., Roussel M.F., Roberts J.M., and Sherr C.J. The p21Cip1 and p27Kip1 Cdk 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18 (1999) 1571-1583
14. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw III E.B., Kaestner K.H., Bartolomei M.S., Shulman G.I., and Birnbaum M.J. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292 (2001) 1728-1731
15. Cozar-Castellano I., Takane K.K., Bottino R., Balamurugan A.N., and Stewart A.F. Induction of β-cell proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirus-mediated transfer of cyclin-dependent kinase-4 and cyclin D1. Diabetes 53 (2004) 149-159
16. Cozar-Castellano I., Fiaschi-Taesch N., Bigatel T.A., Takane K.K., Garcia-Ocana A., Vasavada R., and Stewart A. Molecular control of cell cycle progression in the pancreatic β-cell. Endocr. Rev. 27 (2006) 356-370
17. Cozar-Castellano I., Haught M., and Stewart A.F. The cell cycle inhibitory protein p21cip is not essential for maintaining β-cell cycle arrest or β-cell function in vivo. Diabetes 55 (2006) 3271-3278
18. Cozar-Castellano I., Weinstock M., Haught M., Velázquez-Garcia S., Sipula D., and Stewart A.F. Evaluation of β-cell replication in mice transgenic for hepatocyte growth factor and placental lactogen. Comprehensive characterization of the G1/S regulatory proteins reveals unique involvement of p21cip. Diabetes 55 (2006) 70-77
19. Chung D.C., Brown S.B., Grahme-Cooke F., Seto M., Warshaw A.L., Jensen R.T., and Arnold A. Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. J. Clin. Endocrinol. Metab. 85 (2000) 4373-4378
20. Crabtree J.S., Scacheri P.C., Ward J.M., McNally S.R., Swain G.P., Montagna C., Hager J.H., Hanahan D., Edlund H., Magnuson M.A., Garrett-Beal L., Burns A.L., Ried T., Chandrasekharappa S.C., Marx S.J., Spiegel A.M., and Collins F.S. Of Mice and MEN1: insulinoma in a conditional mouse knockout. Mol. Cell. Biol. 23 (2003) 6075-6085
21. Dalgaard L.T., Billestrup N., and Nielsen J.H. STAT5 activity in pancreatic β-cells. Expert Rev. Endocrinol. Metab. 3 (2008) 423-439
22. Deng C., Zhang P., Wade Harper J., Elledge S.J., and Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82 (1995) 675-684
23. Dor Y., Brown J., Martinez O.I., and Melton D.A. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429 (2004) 41-46
24. Downward J. PI 3-kinase, Akt and cell survival. Semin. Cell Dev. Biol. 15 (2004) 177-182
25. Dunlop M., Muggli E., and Clark S. Association of cyclin-dependent kinase-4 and cyclin D1 in neonatal β cells after mitogenic stimulation by lysophosphatidic acid. Biochem. Biophys. Res. Commun. 218 (1996) 132-136
26. Fatrai S., Elghazi L., Balcazar N., Cras-Meneur C., Krits I., Kiyokawa H., and Bernal-Mizrachi E. Akt induces beta-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes 55 (2006) 318-325
27. Finegood D.T., Scaglia L., and Bonner-Weir S. Dynamics of β-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44 (1995) 249-256
28. Flamez D., Gilon P., Moens K., Van Breusegem A., Delmeire D., Scrocchi L.A., Henquin J.C., Drucker D.J., and Schuit F. Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype. Diabetes 48 (1999) 1979-1986
29. Franklin D.S., Godfrey V.L., O'Brien D.A., Deng C., and Xiong Y. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol. Cell. Biol. 20 (2000) 6147-6158
30. Freemark M., Avril I., Fleenor D., Driscoll P., Petro A., Opara E., Kendall W., Oden J., Bridges S., Binart N., Breant B., and Kelly P. Targeted deletion of the PRL receptor: effect on islet development, insulin production, and glucose tolerance. Endocrinology 143 (2002) 1378-1385
31. Friedrichsen B.N., Galsgaard E.D., Nielsen J.N., and Møldrup A. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5. Mol. Endocrinol. 15 (2001) 136-148
32. Friedrichsen B.N., Richter H.E., Hansen J.A., Rhodes C.J., Nielsen J.H., Billestrup N., and Møldrup A. Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic β-cells. Mol. Endocrinol. 17 (2003) 945-958
33. Friedrichsen B.N., Neubauer N., Lee Y.C., Gram V.K., Blume N., Petersen J.S., Nielsen J.H., and Mødrup A. Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J. Endocrinol. 188 (2006) 481-492
34. Garcia-Ocaña A., Takane K.K., Syed M.A., Philbrick W.M., Vasavada R.C., and Stewart A.F. Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J. Biol. Chem. 275 (2000) 1226-1232
35. Georgia S., and Bhushan A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J. Clin. Invest. 114 (2004) 963-968
36. Georgia S., and Bhushan A. p27 regulates the transition of β-cell from quiescence to proliferation. Diabetes 55 (2006) 2950-2956
37. Guillemain G., Filhoulaud G., Da Silva-Xavier G., Rutter G.A., and Scharfmann R. Glucose is necessary for embryonic pancreatic endocrine cell differentiation. J. Biol. Chem. 282 (2007) 155228-215237
38. Gupta R.K., Gao N., Gorski R.K., White P., Hardy O.T., Rafiq K., Brestelli J.E., Chen G., Stoeckert C.J., and Kaestner K.H. Expansion of adult β-cell mass in response to increased metabolic demand is dependent on HNF-4α. Genes Dev. 21 (2007) 756-769
39. Hagman D.K., Latour M.G., Chakrabarti S.K., Fronts G., Amyot J., Tremblay C., Semache M., Lausier J.A., Roskens V., Mirmira R.G., Jetton T.L., and Poitout V. Cyclical and alternating infusions of glucose and intralipid in rats inhibit insulin gene expression and Pdx-1 binding in islets. Diabetes 57 (2008) 424-431
40. Hanley N.A., Hanley K.P., Miettinen P.J., and Otonkoski T. Weighing up β-cell mass in mice and humans: self-renewal, progenitors or stem cells?. Mol. Cell. Endocrinol. 288 (2008) 79-85
41. Hashimoto N., Kido Y., Uchida T., Asahara S., Shigeyama Y., Matsuda T., Takeda A., Tsuchihashi D., Nishizawa A., Ogawa W., Fujimoto Y., Okamura H., Arden K.C., Herrera P.L., Noda T., and Kasuga M. Ablation of PDK1 in pancreatic β cells induces diabetes as a result of loss of β cell mass. Nat. Genet. 38 (2006) 589-593
42. Heit J.J., Karnik S.K., and Kim S.K. Intrinsic regulators of pancreatic β-cell proliferation. Annu. Rev. Cell Dev. Biol. 22 (2006) 311-338
43. Heit J.J., Apelqvist A.A., Gu X., Winslow M.M., Neilson J.R., Crabtree G.R., and Kim S.K. Calcineurin/NFAT signalling regulates pancreatic β-cell growth and function. Nature 443 (2006) 345-349
44. Hellerström C., Swenne I., and Andersson A. Islet replication and diabetes. In: Lefebvre P.J., and Pipeleers D.G. (Eds). The Pathology of the Endocrine Pancreas in Diabetes (1988), Springer Verlag, Heidelberg, Germany 141-170
45. Hino S., Yamaoka T., Yamashita Y., Yamada T., Hata J., and Itakura M. In vivo proliferation of differentiated pancreatic islet beta cells in transgenic mice expressing mutated cyclin-dependent kinase 4. Diabetologia 47 (2004) 1819-1830
46. Hügl S.R., White M.F., and Rhodes C.J. Insulin-like growth factor I (IGF-I)-stimulated pancreatic β-cell growth is glucose-dependent. J. Biol. Chem. 273 (1998) 17771-17779
47. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J.-L., Schroter M., Burns K., Mattmann C., Rimoldi D., Frenchk L.E., and Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 388 (1997) 190-195
48. Jackerott M., Møldrup A., Thams P., Galsgaard E.D., Knudsen J., Lee Y.C., and Nielsen J.H. STAT5 activity in pancreatic β-cells influences the severity of diabetes in animal models of type 1 and 2 diabetes. Diabetes 55 (2006) 2705-2712
49. Jonas J.C., Sharma A., Hasenkamp W., Ilkova H., Patanè G., Laybutt L., Bonner-Weir S., and Weir G.C. Chronic hyperglycemia triggers loss of Pancreatic β Cell differentiation in an animal model of diabetes. J. Biol. Chem. 274 (1999) 14112-14121
50. Jensen J., Galsgaard E.D., Karlsen A.E., Lee Y.C., and Nielsen J.H. STAT5 activation by human GH protects insulin-producing cells against interleukin-1β, interferon-β and tumour necrosis factor-β-induced apoptosis independent of nitric oxide production. J. Endocrinol. 187 (2005) 25-36
51. Jetton T.L., Everill B., Lausier J., Roskens V., Habibovic A., LaRock K., Gokin A., Peshavaria M., and Leahy J.L. Enhanced β-cell mass without increased proliferation following chronic mild glucose infusion. Am. J. Physiol. Endocrinol. Metab. 294 (2008) E679-E687
52. Karnik S.K., Hughes C.M., Gu X., Rozenblatt-Rosen O., McLean G.W., Xiong Y., Meyerson M., and Kim S.K. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27kip1 and p18INK4c. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 14659-14664
53. Karnik S.K., Chen H., McLean G.W., Heit J.J., Gu X., Zhang A.Y., Fontaine M., Yen M.H., and Kim S.K. Menin controls growth of pancreatic β-cells in pregnant mice and promotes gestational diabetes mellitus. Science 318 (2007) 806-809
54. Kim M.-J., Kang J.-H., Park Y.G., Ryu G.R., KO. S.H., Jeong I.-K., Koh K.-H., Rhie D.-J., Yoon S.H., Hahn S.J., Kim M.-S., and Jo Y.-H. Exendin-4 induction of cyclin D1 expression in INS-1 β-cells: involvement of cAMP-responsive element. J. Endocrinol. 188 (2006) 623-633
55. Klinger S., Poussin C., Debril M.-B., Dolci W., Halban P.A., and Thorens B. Increasing GLP-1-induced β-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-α and DUSP14. Diabetes 57 (2008) 584-593
56. Krishnamurthy J., Torrice C., Ramsey M.R., Kovalev G.I., Al-Regaiey A.K., Su L., and Sharpless N.E. INK4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114 (2004) 1299-1307
57. Krishnamurthy J., Ramsey M.R., Ligon K.L., Torrice C., Koh A., Bonner-Weir S., and Sharpless N.E. p16 induces an age-dependent decline in islets regenerative potential. Nature 443 (2006) 453-457
58. Kushner J.A., Ciemerych M.A., Sicinska E., Wartschow L.M., Teta M., Long S.Y., Sicinski P., and White M.F. Cyclins D2 and D1 are essential for postnatal pancreatic β-cell growth. Mol. Cell. Biol. 25 (2005) 3752-3762
59. Kushner J.A. β-cell growth, an unusual paradiagm of organogenesis that is cyclin D2/Cdk4 dependent. Cell Cycle 5 (2006) 234-237
60. Kulkarni R.N., Jhala U.S., Winnay J.N., Krajewski S., Montminy M., and Kahn C.R. PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J. Clin. Invest. 114 (2004) 828-836
61. La P., Yang Y., Karnik S.K., Silva A.C., Schnepp R.W., Kim S.K., and Hua X. Menin-meidated caspase 8 expression in suppressing multiple endocrine neoplasia type 1. J. Biol. Chem. 282 (2007) 31332-31340
62. LaBaer J., Garret M.D., Stevenson L.F., Slingerland J.M., Sandhu C., Chou H.S., Fattaey A., and Harlow E. New functional activities for the p21 family of Cdk inhibitors. Genes Dev. 11 (1997) 847-862
63. Lawrence J.M., Chen W., Contreras R., and Sacks D.A. Trends in the prevalence of pre-existing diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care 31 (2008) 899-904
64. Lee C.S., De Leon D.D., Kaestner K.H., and Stoffers D.A. Regeneration of pancreatic islets after partial pancreatectomy in mice does not involve the reactivation of neurogenin-3. Diabetes 55 (2006) 269-272
65. Lee H.C., Bonner-Weir S., Weir G.C., and Leahy J.L. Compensatory adaptation to partial pancreatectomy in the rat. Endocrinology 124 (1989) 1571-1575
66. Liadis N., Salmena L., Kwan E., Tajmir P., Schroer S.A., Radziszewska A., Li X., Sheu L., Eweida M., Xu S., Gaisano H.Y., Hakem R., and Woo M. Distinct in vivo roles of caspase-8 in β-cells in physiological and diabetes models. Diabetes 56 (2007) 2302-2311
67. Lingohr M.K., Briaud I., Dickson L.M., McCuaig J.F., Alάrcon C., Wicksteed B.L., and Rhodes C.J. Specific regulation of IRS-2 expression by glucose in rat primary pancreatic islet β-cells. J. Biol. Chem. 281 (2006) 15884-15892
68. Liu J.-L., Coschigano K.T., Robertson K., Lipsett M., Guo Y., Kopchick J.J., Kumar U., and Liu Y.L. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am. J. Physiol. Endocrinol. Metab. 287 (2004) E405-E413
69. Liu Z., and Habener J.F. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. J. Biol. Chem. 283 (2008) 8723-8735
70. Maedler K., Fontana A., Ris F., Sergeev P., Toso C., Oberholzer J., Lehmann R., Bachmann F., Tasinato A., Spinas G.A., Halban P.A., and Donath M.Y. FLIP switches Fas-mediated glucose signaling in human pancreatic cells from apoptosis to cell replication. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 8236-8241
71. Maedler K., Schumann D.M., Schulthess F., Oberholzer J., Bosco D., Berney T., and Donath M.Y. Aging correlates with decreased ß-Cell proliferative capacity and enhanced sensitivity to apoptosis: a potential role for Fas and Pancreatic Duodenal Homeobox-1. Diabetes 55 (2006) 2455-2462
72. Martin J., Hunt S.L., Dubus P., Sotillo R., Néhmé-Pélluard F., Magnuson M.A., Parlow A.F., Malumbres M., Ortega S., and Barbacid M. Genetic rescue of Cdk4 null mice restores pancreatic. β-cell proliferation but not homeostatic cell number. Oncogene 22 (2003) 5261-5269
73. Marzo N., Mora C., Fabregat M.E., Martin J., Usac E.F., Franco C., Barbacid M., and Gomis R. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes. Diabetologia 47 (2004) 686-694
74. Mattison J.A., Roth G.S., Ingram D.K., and Lane M.A. Endocrine effects of dietary restriction and aging: the National Institute on Aging Study. J.Anti-Aging Med. 4 (2001) 215-223
75. McEvoy R.C. Changes in the volumes of the A-, B- and D-cell populations in the pancreatic islets during the postnatal development of the rat. Diabetes 30 (1981) 813-817
76. Menge B.A., Tannapfel A., Belyaev O., Dreccher R., Müller C., Uhl W., Schmidt W.E., and Meier J.J. Partial pancreatectomy in adult human does not provoke β-cell regeneration. Diabetes 57 (2008) 142-149
77. Miettinen P.J., Ustinov J., Ormio P., Gao R., Palgi J., Hakonen E., Juntti-Berggren L., Berggren P.-O., and Otonkoski T. Downregulation of EGF receptor signaling in pancreatic islets causes diabetes due to impaired postnatal β-cell growth. Diabetes 55 (2006) 3299-3308
78. Milne T.A., Hughes C.M., Lloyd R., Yang Z., Rozenblatt-Rosen O., Dou Y., Schnepp R.W., Krankel C., LiVolsi V.A., Gibbs D., Hua X., Roeder R., Meyerson M., and Hess J.L. Menin and MLL cooperatively regulate expression of cyclin dependent kinase inhibitors. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 749-754
79. Meier J.J., Butler A.E., Saisho Y., Monchamp T., Galasso R., Bhushan A., Rizza R.A., and Butler P.C. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 57 (2008) 1584-1594
80. Mussmann R., Geese M., Harder F., Kegel S., Andag U., Lomow A., Burk U., Onichtchouk D., Dohrmann C., and Austen M. Inhibition of GSK3 promotes replication and survival of pancreatic beta cells. J. Biol. Chem. 282 (2007) 12030-12037
81. Nguyen K.-T.T., Tajmir P., Lin C.H., Liadis N., Zhu X.-D., Eweida M., Tolasa-Karaman G., Cai F., Wang R., Kitamura T., Belsham D.D., Wheeler M.B., Akira Suzuki A., Mak T.W., and Minna Woo M. Essential role of Pten in body size determination and pancreatic ß-Cell homeostasis in vivo. Mol. Cell. Biol. 26 (2006) 4511-4518
82. Nielsen G.P., Stemmer-Rachamimov A.O., Shaw J., Roy J.E., Koh J., and Louis D.N. Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues. Lab Invest. 79 (1999) 1137-1143
83. Nielsen J.H., Brunstedt J., Andersson A., and Frimodt-Møller C. Preservation of beta cell function in adult human pancreatic islets for several months in vitro. Diabetologia 16 (1979) 97-100
84. Nielsen J.H., Galsgaard E.D., Møldrup A., Friedrichsen B.N., Billestrup N., Hansen J.A., Lee Y.C., and Carlsson C. Regulation of β-cell mass by hormones and growth factors. Diabetes 50 Suppl. 1 (2001) S25-S29
85. Ogino J., Sakurai K., Yoshiwara K., Suzuki Y., Ishizuka N., Seki N., Susuki Y., Koseki H., Shirasawa T., Hashimoto N., Yagui K., and Saito Y. Insulin resistance and increased pancreatic β-cell proliferation in mice expressing a mutant insulin receptor (P1195L). J. Endocrinol. 190 (2006) 739-747
86. Okada T., Liew C.W., Hu J., Hinault C., Michael M.D., Krutzfeldt J., Yin C., Holzenberger M., Stoffel M., and Kulkarni R.N. Insulin receptors in β-cells are critical for islet compensatory growth response to insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 8977-8982
87. Olson L.K., Sharma A., Peshavaria M., Wright C.V.E., Towle H.C., Robertson R.P., and Stein R. Reduction of insulin gene transcription in HIT-T15 cells chronically exposed to a supraphysiological glucose concentration is associated with loss of STF-1 transcription factor expression. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 9127-9131
88. Papadopoulou S., and Edlund H. Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function. Diabetes 54 (2005) 2844-2851
89. Park S., Dong X., Fisher T.L., Dunn S., Omer A.K., Weir G., and White M.F. Exendin-4 uses Irs2 signaling to mediate pancreatic b cell growth and function. J. Biol. Chem. 281 (2006) 1159-1168
90. Parnaud G., Bosco D., Berney T., Pattou F., Kerr-Conte J., Donath M.Y., Bruun C., Mandrup-Poulsen T., Billestrup N., and Halban P.A. Proliferation of sorted human and rat beta cells. Diabetologia 51 (2008) 91-100
91. Parsons J.A., Brelje T.C., and Sorenson R.L. Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology 130 (1992) 1459-1466
92. Parsons J.A., Bartke A., and Sorensons R.L. Number and size of islets of Langehans in pregnancy, human growth hormone-expressing transgenic and pituitary dwarf mice: effect of lactogenic hormones. Endocrinology 136 (1995) 2013-2021
93. Pershavaria M., Larmie B.L., Lausier J., Satish B., Habiboviv A., Roskens V., Larock K., Everill B., Leahy J.L., and Jetton T.L. Regulation of pancreatic β-cell regeneration in normoglycemic 60% partial-pancreatectomy mouse. Diabetes 55 (2006) 3289-3296
94. Poitout V., and Robertson R.P. Minireview: secondary β-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology 143 (2002) 339-342
95. Prentki M., and Nolan C.J. Islet b cell failure in type 2 diabetes. J. Clin. Invest. 116 (2006) 1802-1812
96. Rane S.G., Dubus P., Mettus R.V., Galbreath E.J., Boden G., Reddy E.P., and Barbacid M. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta islet cell hyperplasia. Nat. Genet. 22 (1999) 44-52
97. Rulifson I.C., Karnik S.K., Heiser P.W., Berge D.T., Chen H., Gu X., Taketo M.M., Nusse R., Hebrok M., and Kim S.K. Wnt signaling regulates pancreatic β cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 6247-6252
98. Saisho Y., Butler A.E., Meier J.J., Monchamp T., Allen-Auerbach M., Rizza R.A., and Butler P.C. Pancreas volumns in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin. Anat. 20 (2007) 933-942
99. Sayo Y., Murao K., Imachi H., Cao W.M., Sato M., Dobashi H., Wong N.W., and Ishida T. The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells. Endocrinology 143 (2002) 2437-2440
100. Scaglia L., Smith F.E., and Bonner-Weir S. Apoptosis contributes to the involution of beta cell mass in the post partum rat pancreas. Endocrinology 136 (1995) 5461-5468
101. Schnepp R.W., Chen Y.-X., Wang H., Cash T., Silva A., Diehl J.A., Brown E., and Hua X. Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells. Cancer Res. 66 (2006) 5707-5715
102. Schisler J.C., Fueger P.T., Babu D.A., Hohmeier H.E., Tessem J.S., Lu D., Becker T.C., Naziruddin B., Levy M., Mirmira R.G., and Newgard C.B. Stimulation of human and rat islet β-cell proliferation with retention of function by the homeodomain transcription factor Nkx6.1. Mol. Cell. Biol. 28 (2008) 3465-3476
103. Serup P., and Nielsen J.H. Development and life cycle of a beta cell. In: DeFronzo R.A., Ferrannini E., Keen H., and Zimmet P. (Eds). International Textbook of Diabetes Mellitus. 3rd edition (2004), John Wiley & Sons, Chichester 59-78
104. Spalding K.L., Arner E., Wetermark P.O., Bernard S., Bucholz B.A., Bergmann O., Blomqvist L., Hoffstedt J., Näslund E., Britton T., Concha H., Hassan M., Rydén M., Frisén J., and Arner P. Dynamics of fat cell turnover in humans. Nature 453 (2008) 783-787
105. Srinivasan S., Bernal-Mizrachi E., Ohsugi M., and Permutt M.A. Glucose promotes pancreatic islet β-cell survival through a PI 3-kinase/Akt-signaling pathway. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E784-E793
106. Srinivasan S., Ohsugi M., Liu Z., Fatrai S., Bernal-Mizrachi E., and Permutt M.A. Endoplasmic reticulum stress-induced apoptosis is partly mediated by reduced insulin signaling through phosphatidylinositol 3-Kinase/Akt and increased glycogen synthase kinase-3 in mouse insulinoma cells. Diabetes 54 (2005) 968-975
107. Swenne I. Effects of aging on the regenerative capacity of the pancreatic B-cell of the rat. Diabetes 32 (1983) 14-19
108. Swenne I. Glucose-stimulated DNA replication of the pancreatic islets during the development of the rat fetus. Effects of nutrients, growth hormone, and triiodothyronine. Diabetes 34 (1985) 803-807
109. Teta M., Long S.Y., Wartschow L.M., Rankin M.M., and Kushner J.A. Very slow turnover of β-cells in aged adult mice. Diabetes 54 (2005) 2557-2567
110. Teta M., Rankin M.M., Long S.Y., Stein G.M., and Kushner J.A. Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev. Cell 12 (2007) 817-826
111. Tsutsui T., Hesabi B., Moons D.S., Pandolfi P.P., Hansel K.S., Koff A., and Kiyokawa H. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27kip1 activity. Mol. Cell. Biol. 19 (1999) 7011-7019
112. Tuttle R.L., Gill N.S., Pugh W., Lee J.-P., Koeberlein B., Furth E.E., Polonsky K.S., Naji A., and Birnbaum M.J. Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα. Nat. Med. 7 (2001) 1133-1137
113. Uchida T., Nakamura T., Hashimoto N., Matsuda T., Kotani K., Sakaue H., Kido Y., Hayashi Y., Nakayama K.I., White M.F., and Masato Kasuga M. Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat. Med. 11 (2005) 175-182
114. Vasavada R.C., Garcia-Ocaña A., Zawalich W.S., Sorenson R.L., Dann P., Syed M., Ogren L., Talamantes F., and Stewart A.F. Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypoglycemia. J. Biol. Chem. 275 (2000) 15399-15406
115. Wang R.N., Klöppel G., and Bouwens L. Duct-to islets-cell differentiation and islet growth in pancreas of duct-ligated adult rats. Diabetologia 38 (1995) 1405-1411
116. Wither D.J., Gutierrez J.S., Towery H., Burks D.J., Ren J.-M., Previs S., Zhang Y., Bernal D., Pons S., Shulman G.I., Bonner-Weir S., and White M.F. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 39 (1998) 900-904
117. Withers D.J., Burks D.J., Towery H., Altamuro S.L., Flint C.L., and White M.F. Irs-2 coordinates igf-1 receptor-mediated β-cell development and peripheral insulin signalling. Nat. Genet. 23 (1999) 32-40
118. Xu X., D'Hoker J., Stangé G., Bonné S., De Leu N., Xiao X., Van De Casteele M., Mellitzer G., Ling Z., Pipeleers D., Bouwens L., Scharfmann R., Gradwohl G., and Heimberg H. β cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 132 (2008) 197-207
119. Zhang F., Sjöholm A., and Zhang Q. Growth hormone signalling in pancreatic β-cells-calcium handling regulated by growth hormone. Mol. Cell. Endocrinol 297 (2009) 50-57
120. Zhang X., Gaspard J.P., Mizukami Y., Li J., Graeme-Cook F., and Chung D. Overexpression of cyclin D1 in pancreatic β-cells in vivo results in islet hyperplasia without hypoglycemia. Diabetes 54 (2005) 712-719